Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Paraganglioma × cixutumumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 5 Rhabdomyosarcoma 4 Neoplasms 4 Osteosarcoma 3 Breast Neoplasms 3 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Adrenocortical Carcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neuroectodermal Tumors 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Leiomyosarcoma 1 Insulin-Like Growth Factor I, Resistance To 1 Hepatoblastoma 1 Hemangiosarcoma 1

Interventions

3-Iodobenzylguanidine 3 pazopanib 1 lutetium Lu 177 dotatate 1 guadecitabine 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Radiosurgery 1 Phenoxybenzamine 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Axitinib 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡